{
  "id": "diabetic-neuropathy",
  "title": "Diabetic Neuropathy",
  "version": "1.0",
  "icd10": [
    "** E11.40 (Type 2 diabetes with diabetic neuropathy",
    "unspecified)",
    "E11.41 (Type 2 diabetes with diabetic mononeuropathy)",
    "E11.42 (Type 2 diabetes with diabetic polyneuropathy)",
    "E10.40-E10.42 (Type 1 equivalents)",
    "G63.2 (Diabetic polyneuropathy)",
    "G62.9 (Polyneuropathy",
    "unspecified)"
  ],
  "scope": "** Evaluation and management of diabetic neuropathy in adults including distal symmetric polyneuropathy (most common), painful diabetic neuropathy, diabetic autonomic neuropathy, and focal/multifocal neuropathies. Applies to ED, hospital, and outpatient settings.",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Core Labs (All Patients)": [
        {
          "item": "HbA1c (CPT 83036)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Glycemic control; correlates with neuropathy risk",
          "target": "<7% (individualized)"
        },
        {
          "item": "Fasting glucose (CPT 82947)",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Current glycemic status",
          "target": "80-130 mg/dL"
        },
        {
          "item": "BMP (CPT 80048)",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE",
          "rationale": "Renal function; uremic neuropathy",
          "target": "Normal"
        },
        {
          "item": "CBC (CPT 85025)",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Anemia (B12 deficiency)",
          "target": "Normal"
        },
        {
          "item": "Vitamin B12 (CPT 82607)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Metformin causes B12 deficiency; coexistent deficiency",
          "target": ">400 pg/mL"
        },
        {
          "item": "Methylmalonic acid (MMA) (CPT 83921)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "If B12 borderline (200-400)",
          "target": "Normal"
        },
        {
          "item": "TSH (CPT 84443)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Hypothyroid neuropathy",
          "target": "Normal"
        },
        {
          "item": "Lipid panel (CPT 80061)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Dyslipidemia contributes to neuropathy",
          "target": "LDL <100 (or <70 if ASCVD)"
        }
      ],
      "Extended Labs (Atypical Presentations)": [
        {
          "item": "SPEP/UPEP with immunofixation (CPT 86334, 86335)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Monoclonal gammopathy-associated neuropathy",
          "target": "No M-spike"
        },
        {
          "item": "Serum free light chains",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "If SPEP negative but suspicion",
          "target": "Normal ratio"
        },
        {
          "item": "Liver function tests (CPT 80076)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Hepatic disease, alcohol",
          "target": "Normal"
        },
        {
          "item": "HIV (CPT 87389)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "If risk factors",
          "target": "Negative"
        },
        {
          "item": "RPR/VDRL (CPT 86592)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Syphilis if atypical",
          "target": "Nonreactive"
        },
        {
          "item": "ESR (CPT 85652), CRP (CPT 86140)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Inflammatory/vasculitic neuropathy",
          "target": "Normal"
        },
        {
          "item": "ANA (CPT 86235)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "If connective tissue disease suspected",
          "target": "Negative"
        },
        {
          "item": "Anti-GAD65, IA-2 antibodies (CPT 86235)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "If type uncertain; LADA",
          "target": "Document"
        }
      ],
      "Specialized Labs (Diabetic Amyotrophy/Atypical)": [
        {
          "item": "CSF analysis (CPT 89051, 84157, 82945)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Elevated protein in DLRPN; r/o inflammatory",
          "target": "Mild protein elevation in DLRPN"
        },
        {
          "item": "Paraneoplastic panel",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "If rapid progression, weight loss",
          "target": "Negative"
        }
      ]
    },
    "Imaging & Studies": {
      "Electrodiagnostic Studies": [
        {
          "item": "Nerve conduction studies (NCS) (CPT 95907-95913)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Baseline; atypical cases",
          "target": "Axonal sensorimotor polyneuropathy",
          "contraindications": "Pacemaker (relative); anticoagulation (relative)"
        },
        {
          "item": "Electromyography (EMG) (CPT 95886)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "If motor involvement; amyotrophy",
          "target": "Denervation in affected muscles",
          "contraindications": "Active infection at site"
        },
        {
          "item": "Quantitative sensory testing (QST)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Small fiber neuropathy; research",
          "target": "Abnormal thermal thresholds",
          "contraindications": "None"
        }
      ],
      "Autonomic Testing": [
        {
          "item": "Cardiovascular autonomic reflex tests (CPT 95924)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "If CAN suspected",
          "target": "Abnormal HR variability, Valsalva ratio",
          "contraindications": "Arrhythmias"
        },
        {
          "item": "Tilt table test (CPT 95924)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Orthostatic hypotension evaluation",
          "target": "Orthostatic BP drop without HR rise",
          "contraindications": "Severe coronary disease"
        },
        {
          "item": "Sudomotor function (QSART) (CPT 95924)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Sudomotor dysfunction",
          "target": "Reduced sweat output",
          "contraindications": "None"
        },
        {
          "item": "Gastric emptying study",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "If gastroparesis suspected",
          "target": "Delayed emptying",
          "contraindications": "None"
        }
      ],
      "Small Fiber Neuropathy Assessment": [
        {
          "item": "Skin punch biopsy (IENFD) (CPT 11104)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Small fiber neuropathy; normal NCS",
          "target": "Reduced intraepidermal nerve fiber density",
          "contraindications": "Anticoagulation (relative)"
        },
        {
          "item": "Corneal confocal microscopy",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Non-invasive small fiber assessment",
          "target": "Reduced corneal nerve fiber density",
          "contraindications": "None"
        },
        {
          "item": "MRI lumbosacral plexus (CPT 72148)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Diabetic amyotrophy; asymmetric weakness",
          "target": "Plexus/root enhancement in DLRPN",
          "contraindications": "Pacemaker, metal"
        },
        {
          "item": "MRI spine (CPT 72141)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "R/o structural if myelopathy suspected",
          "target": "R/o compression",
          "contraindications": "Same"
        }
      ]
    },
    "Treatment": {
      "Glycemic Control (Foundation of Treatment)": [
        {
          "item": "Intensive glycemic control",
          "route": "-",
          "indication": "Prevent progression of diabetic neuropathy via tight glucose management",
          "dosing": {
            "doseOptions": [
              {
                "text": "7%",
                "orderSentence": "Intensive glycemic control 7% -"
              }
            ],
            "route": "-",
            "instructions": "Target HbA1c <7% (individualized); avoid hypoglycemia",
            "orderSentence": "Intensive glycemic control 7% -"
          },
          "contraindications": "Hypoglycemia unawareness with CAN",
          "monitoring": "HbA1c q3 months until stable",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Continuous glucose monitoring",
          "route": "-",
          "indication": "Real-time glucose tracking for hypoglycemia unawareness in autonomic neuropathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Continuous glucose monitoring N/A -"
              }
            ],
            "route": "-",
            "instructions": "If hypoglycemia unawareness",
            "orderSentence": "Continuous glucose monitoring N/A -"
          },
          "contraindications": "None",
          "monitoring": "Sensor accuracy",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Neuropathic Pain - First-Line Agents": [
        {
          "item": "Duloxetine (Cymbalta)",
          "route": "PO",
          "indication": "First-line SNRI for painful diabetic peripheral neuropathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "30 mg",
                "orderSentence": "Duloxetine (Cymbalta) 30 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "30 mg daily × 1 week, then 60 mg daily; max 120 mg/day",
            "orderSentence": "Duloxetine (Cymbalta) 30 mg PO"
          },
          "contraindications": "MAOIs, uncontrolled glaucoma, hepatic impairment",
          "monitoring": "Nausea, BP; serotonin syndrome",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Pregabalin (Lyrica)",
          "route": "PO",
          "indication": "First-line anticonvulsant for painful diabetic neuropathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "50 mg",
                "orderSentence": "Pregabalin (Lyrica) 50 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "50 mg TID or 75 mg BID; titrate to 300 mg/day; max 600 mg/day",
            "orderSentence": "Pregabalin (Lyrica) 50 mg PO"
          },
          "contraindications": "CrCl <60: reduce dose",
          "monitoring": "Sedation, edema, weight gain; renal dosing",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Gabapentin (Neurontin)",
          "route": "PO",
          "indication": "First-line anticonvulsant for neuropathic pain in diabetic neuropathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "300 mg",
                "orderSentence": "Gabapentin (Neurontin) 300 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "300 mg QHS, titrate by 300 mg q3-7 days; target 1800-3600 mg/day divided TID",
            "orderSentence": "Gabapentin (Neurontin) 300 mg PO"
          },
          "contraindications": "CrCl <60: reduce dose",
          "monitoring": "Sedation, edema; renal dosing",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Neuropathic Pain - Second-Line Agents": [
        {
          "item": "Venlafaxine XR",
          "route": "PO",
          "indication": "Second-line SNRI for painful diabetic neuropathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "37.5-75 mg",
                "orderSentence": "Venlafaxine XR 37.5-75 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "37.5-75 mg daily; titrate to 150-225 mg/day",
            "orderSentence": "Venlafaxine XR 37.5-75 mg PO"
          },
          "contraindications": "MAOIs, uncontrolled HTN",
          "monitoring": "BP; serotonin syndrome",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Amitriptyline",
          "route": "PO",
          "indication": "Second-line TCA for neuropathic pain in diabetic neuropathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "10-25 mg",
                "orderSentence": "Amitriptyline 10-25 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "10-25 mg QHS; titrate to 50-100 mg QHS",
            "orderSentence": "Amitriptyline 10-25 mg PO"
          },
          "contraindications": "Cardiac disease, glaucoma, urinary retention",
          "monitoring": "ECG if >100 mg; anticholinergic effects",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Nortriptyline",
          "route": "PO",
          "indication": "Second-line TCA for neuropathic pain with fewer anticholinergic effects",
          "dosing": {
            "doseOptions": [
              {
                "text": "10-25 mg",
                "orderSentence": "Nortriptyline 10-25 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "10-25 mg QHS; titrate to 75 mg QHS",
            "orderSentence": "Nortriptyline 10-25 mg PO"
          },
          "contraindications": "Same as amitriptyline",
          "monitoring": "Same; fewer anticholinergic effects",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Neuropathic Pain - Topical Agents": [
        {
          "item": "Capsaicin 8% patch (Qutenza)",
          "route": "Transdermal",
          "indication": "Localized neuropathic pain in painful diabetic neuropathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Capsaicin 8% patch (Qutenza) N/A Transdermal"
              }
            ],
            "route": "Transdermal",
            "instructions": "Apply to painful area × 30-60 min q3 months; in-office",
            "orderSentence": "Capsaicin 8% patch (Qutenza) N/A Transdermal"
          },
          "pretreatment": "-",
          "contraindications": "Open wounds; capsaicin allergy",
          "monitoring": "BP during application; pain",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Lidocaine 5% patch",
          "route": "Transdermal",
          "indication": "Topical analgesia for localized painful diabetic neuropathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Lidocaine 5% patch N/A Transdermal"
              }
            ],
            "route": "Transdermal",
            "instructions": "Up to 3 patches daily; 12h on/12h off",
            "orderSentence": "Lidocaine 5% patch N/A Transdermal"
          },
          "pretreatment": "-",
          "contraindications": "Allergy to local anesthetics",
          "monitoring": "Local irritation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Capsaicin cream 0.075%",
          "route": "Topical",
          "indication": "Low-concentration topical analgesic for mild neuropathic pain",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Capsaicin cream 0.075% N/A Topical"
              }
            ],
            "route": "Topical",
            "instructions": "Apply TID-QID; takes 2-4 weeks for effect",
            "orderSentence": "Capsaicin cream 0.075% N/A Topical"
          },
          "pretreatment": "-",
          "contraindications": "Open wounds",
          "monitoring": "Initial burning (improves)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Neuropathic Pain - Third-Line/Refractory": [
        {
          "item": "Tramadol",
          "route": "PO",
          "indication": "Third-line opioid analgesic for refractory painful diabetic neuropathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "50-100 mg",
                "orderSentence": "Tramadol 50-100 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "50-100 mg q4-6h PRN; max 400 mg/day",
            "orderSentence": "Tramadol 50-100 mg PO"
          },
          "contraindications": "Seizure disorder, opioid dependence, MAOIs",
          "monitoring": "Seizures; serotonin syndrome; dependence",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Tapentadol ER",
          "route": "PO",
          "indication": "Dual-mechanism opioid for refractory painful diabetic neuropathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "50 mg",
                "orderSentence": "Tapentadol ER 50 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "50 mg BID; titrate by 50 mg q3 days; max 500 mg/day",
            "orderSentence": "Tapentadol ER 50 mg PO"
          },
          "contraindications": "Respiratory depression, severe hepatic impairment",
          "monitoring": "Respiratory; GI effects",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Spinal cord stimulation",
          "route": "-",
          "indication": "Neuromodulation for severe refractory painful diabetic neuropathy",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Spinal cord stimulation N/A -"
              }
            ],
            "route": "-",
            "instructions": "Referral to interventional pain for refractory cases",
            "orderSentence": "Spinal cord stimulation N/A -"
          },
          "contraindications": "Infection, coagulopathy",
          "monitoring": "Device complications",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-"
        }
      ],
      "Combination Therapy": [
        {
          "item": "Duloxetine + Pregabalin",
          "route": "PO",
          "indication": "Combination therapy for inadequate pain control on monotherapy",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Duloxetine + Pregabalin N/A PO"
              }
            ],
            "route": "PO",
            "instructions": "If monotherapy inadequate; use lower doses of each",
            "orderSentence": "Duloxetine + Pregabalin N/A PO"
          },
          "contraindications": "Per individual agents",
          "monitoring": "Per individual agents",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Gabapentinoid + TCA",
          "route": "PO",
          "indication": "Dual-mechanism combination for refractory neuropathic pain",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Gabapentinoid + TCA N/A PO"
              }
            ],
            "route": "PO",
            "instructions": "If monotherapy inadequate",
            "orderSentence": "Gabapentinoid + TCA N/A PO"
          },
          "contraindications": "Per individual agents",
          "monitoring": "Sedation; anticholinergic",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Diabetic Autonomic Neuropathy Treatment": [
        {
          "item": "Midodrine",
          "dosing": {
            "doseOptions": [
              {
                "text": "2.5-10 mg",
                "orderSentence": "Midodrine 2.5-10 mg -"
              }
            ],
            "route": "-",
            "instructions": "2.5-10 mg TID (last dose before 6 PM)",
            "orderSentence": "Midodrine 2.5-10 mg -"
          },
          "monitoring": "Supine HTN; avoid at night"
        },
        {
          "item": "Metoclopramide",
          "dosing": {
            "doseOptions": [
              {
                "text": "5-10 mg",
                "orderSentence": "Metoclopramide 5-10 mg -"
              }
            ],
            "route": "-",
            "instructions": "5-10 mg before meals; max 12 weeks",
            "orderSentence": "Metoclopramide 5-10 mg -"
          },
          "monitoring": "Tardive dyskinesia (black box)"
        },
        {
          "item": "Sildenafil",
          "dosing": {
            "doseOptions": [
              {
                "text": "25-100 mg",
                "orderSentence": "Sildenafil 25-100 mg -"
              }
            ],
            "route": "-",
            "instructions": "25-100 mg PRN",
            "orderSentence": "Sildenafil 25-100 mg -"
          },
          "monitoring": "Nitrate contraindication"
        },
        {
          "item": "Timed voiding",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Timed voiding N/A -"
              }
            ],
            "route": "-",
            "instructions": "q3-4 hour schedule",
            "orderSentence": "Timed voiding N/A -"
          },
          "monitoring": "Residual volumes"
        },
        {
          "item": "Glycopyrrolate",
          "dosing": {
            "doseOptions": [
              {
                "text": "1-2 mg",
                "orderSentence": "Glycopyrrolate 1-2 mg -"
              }
            ],
            "route": "-",
            "instructions": "1-2 mg BID-TID",
            "orderSentence": "Glycopyrrolate 1-2 mg -"
          },
          "monitoring": "Anticholinergic effects"
        }
      ],
      "Diabetic Amyotrophy (DLRPN) Treatment": [
        {
          "item": "Glycemic control",
          "route": "-",
          "indication": "Foundational glucose optimization for diabetic amyotrophy recovery",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Glycemic control N/A -"
              }
            ],
            "route": "-",
            "instructions": "Optimize; avoid rapid correction",
            "orderSentence": "Glycemic control N/A -"
          },
          "contraindications": "Per diabetes management",
          "monitoring": "HbA1c",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Physical therapy",
          "route": "-",
          "indication": "Prevent contractures and restore strength in diabetic amyotrophy",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Physical therapy N/A -"
              }
            ],
            "route": "-",
            "instructions": "Prevent contractures; strengthen",
            "orderSentence": "Physical therapy N/A -"
          },
          "contraindications": "None",
          "monitoring": "Function",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Pain management",
          "route": "-",
          "indication": "Neuropathic pain control in diabetic amyotrophy per algorithm",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Pain management N/A -"
              }
            ],
            "route": "-",
            "instructions": "Per neuropathic pain algorithm",
            "orderSentence": "Pain management N/A -"
          },
          "contraindications": "Per agent",
          "monitoring": "Per agent",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "IVIG (severe/refractory) (CPT 96365)",
          "route": "IV",
          "indication": "Immunomodulation for severe or refractory diabetic amyotrophy",
          "dosing": {
            "doseOptions": [
              {
                "text": "2 g/kg",
                "orderSentence": "IVIG (severe/refractory) (CPT 96365) 2 g/kg IV"
              }
            ],
            "route": "IV",
            "instructions": "2 g/kg over 2-5 days; may repeat",
            "orderSentence": "IVIG (severe/refractory) (CPT 96365) 2 g/kg IV"
          },
          "contraindications": "IgA deficiency",
          "monitoring": "Renal function; infusion reactions",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "EXT",
          "ICU": "-"
        },
        {
          "item": "Methylprednisolone (CPT 96374)",
          "route": "IV",
          "indication": "High-dose IV steroid for diabetic amyotrophy if IVIG unavailable",
          "dosing": {
            "doseOptions": [
              {
                "text": "1 g",
                "orderSentence": "Methylprednisolone (CPT 96374) 1 g IV"
              }
            ],
            "route": "IV",
            "instructions": "1 g IV daily × 3-5 days; taper (may use if IVIG unavailable)",
            "orderSentence": "Methylprednisolone (CPT 96374) 1 g IV"
          },
          "contraindications": "Uncontrolled DM (relative)",
          "monitoring": "Glucose; infection",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "EXT",
          "ICU": "-"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Neurology",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Atypical presentation, diagnosis confirmation, refractory pain"
        },
        {
          "item": "Endocrinology",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Diabetes optimization"
        },
        {
          "item": "Podiatry",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Foot care, ulcer prevention, nail care"
        },
        {
          "item": "Pain management",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Refractory neuropathic pain"
        },
        {
          "item": "Physical therapy",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Balance, gait, strengthening"
        },
        {
          "item": "Occupational therapy",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Hand function, adaptive equipment"
        },
        {
          "item": "Gastroenterology",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Gastroparesis evaluation/management"
        },
        {
          "item": "Urology",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Bladder dysfunction, erectile dysfunction"
        },
        {
          "item": "Cardiology",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Cardiovascular autonomic neuropathy"
        },
        {
          "item": "Wound care",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Diabetic foot ulcers"
        }
      ],
      "Foot Care & Ulcer Prevention (Critical)": [
        {
          "item": "Daily foot inspection (patient or caregiver)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Monofilament testing annually (10-g Semmes-Weinstein)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Protective footwear; never walk barefoot",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Custom orthotics/diabetic shoes for high-risk feet",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        },
        {
          "item": "Keep feet clean and dry; moisturize (not between toes)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Avoid heating pads; test water temperature with elbow",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Trim toenails straight across; professional care if needed",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Immediate evaluation for any wound, blister, or color change",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "URGENT"
        }
      ],
      "Patient/Family Instructions": [
        {
          "item": "Neuropathy is common in diabetes; can be slowed with good control",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Report new numbness, tingling, weakness, or pain",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Daily foot inspection is critical; use mirror if needed",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Never walk barefoot; check shoes for objects before wearing",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Fall prevention: good lighting, remove rugs, use handrails",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Report dizziness on standing, early satiety, urinary symptoms",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "American Diabetes Association (diabetes.org) resources",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        }
      ],
      "Comorbidity Management": [
        {
          "item": "Statin therapy for dyslipidemia (reduces neuropathy progression)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Blood pressure control <140/90 (or <130/80 if tolerated)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Smoking cessation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Alcohol moderation (<1 drink/day women, <2 men)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Weight management",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        },
        {
          "item": "SGLT2 inhibitor or GLP-1 RA if ASCVD or CKD",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "B12 deficiency neuropathy",
      "features": "Macrocytic anemia; subacute combined degeneration",
      "tests": "B12, MMA; may coexist with DPN"
    },
    {
      "diagnosis": "Alcohol-related neuropathy",
      "features": "Alcohol history; nutritional deficiency",
      "tests": "History; thiamine; may coexist"
    },
    {
      "diagnosis": "Chronic inflammatory demyelinating polyneuropathy",
      "features": "Proximal + distal weakness; demyelinating NCS",
      "tests": "NCS pattern; CSF protein"
    },
    {
      "diagnosis": "Uremic neuropathy",
      "features": "ESRD; improves with dialysis",
      "tests": "Creatinine; dialysis status"
    },
    {
      "diagnosis": "Hypothyroid neuropathy",
      "features": "Carpal tunnel; myopathy; slow relaxation reflexes",
      "tests": "TSH"
    },
    {
      "diagnosis": "Monoclonal gammopathy neuropathy",
      "features": "Often sensory > motor; may have ataxia",
      "tests": "SPEP/UPEP; free light chains"
    },
    {
      "diagnosis": "Hereditary neuropathy (CMT)",
      "features": "Family history; high arches; hammer toes",
      "tests": "Genetic testing; NCS pattern"
    },
    {
      "diagnosis": "Vasculitic neuropathy",
      "features": "Mononeuritis multiplex; stepwise; systemic symptoms",
      "tests": "ESR, CRP; nerve biopsy"
    },
    {
      "diagnosis": "Chemotherapy-induced neuropathy",
      "features": "Temporal relationship to chemo (platinum, taxanes, vincristine)",
      "tests": "History"
    },
    {
      "diagnosis": "HIV neuropathy",
      "features": "Risk factors; CD4 count",
      "tests": "HIV testing"
    }
  ],
  "evidence": [
    {
      "recommendation": "Intensive glycemic control prevents/slows neuropathy",
      "evidenceLevel": "Class I, Level A",
      "source": "[DCCT (DCCT Research Group, NEJM 1993)](https://pubmed.ncbi.nlm.nih.gov/8366922/); [UKPDS 33 (Lancet 1998)](https://pubmed.ncbi.nlm.nih.gov/9742976/)"
    },
    {
      "recommendation": "Duloxetine effective for painful DPN",
      "evidenceLevel": "Class I, Level A",
      "source": "Multiple RCTs; FDA-approved"
    },
    {
      "recommendation": "Pregabalin effective for painful DPN",
      "evidenceLevel": "Class I, Level A",
      "source": "Multiple RCTs; FDA-approved"
    },
    {
      "recommendation": "Gabapentin effective for painful DPN",
      "evidenceLevel": "Class I, Level B",
      "source": "Multiple RCTs"
    },
    {
      "recommendation": "TCAs effective for painful DPN",
      "evidenceLevel": "Class I, Level B",
      "source": "Multiple RCTs"
    },
    {
      "recommendation": "Capsaicin 8% patch effective for localized pain",
      "evidenceLevel": "Class I, Level A",
      "source": "Multiple RCTs; FDA-approved"
    },
    {
      "recommendation": "Midodrine for orthostatic hypotension",
      "evidenceLevel": "Class I, Level A",
      "source": "Multiple RCTs"
    },
    {
      "recommendation": "Annual foot screening reduces amputation risk",
      "evidenceLevel": "Class I, Level A",
      "source": "Multiple studies"
    },
    {
      "recommendation": "Multifactorial risk reduction (lipids, BP, glucose) improves outcomes",
      "evidenceLevel": "Class I, Level B",
      "source": "Multiple studies"
    }
  ],
  "monitoring": [
    {
      "item": "HbA1c",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "q3 months until stable, then q6 months",
      "action": "Intensify diabetes management"
    },
    {
      "item": "Foot exam (monofilament)",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "Every visit; comprehensive annually",
      "action": "Podiatry; protective footwear"
    },
    {
      "item": "Symptom assessment (pain scores)",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "Every visit",
      "action": "Adjust pain medications"
    },
    {
      "item": "Renal function",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "Annually; more if on gabapentinoids",
      "action": "Dose adjust medications"
    },
    {
      "item": "B12 level",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "Annually if on metformin",
      "action": "Supplement"
    },
    {
      "item": "Orthostatic vitals",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "If CAN suspected; every visit",
      "action": "Autonomic treatment"
    },
    {
      "item": "Fall risk assessment",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "Every visit",
      "action": "PT; home safety evaluation"
    }
  ],
  "disposition": [
    {
      "disposition": "Outpatient management",
      "criteria": "Stable neuropathy; adequate pain control; no active ulcers"
    },
    {
      "disposition": "Admit to hospital",
      "criteria": "Severe uncontrolled pain; infected diabetic foot ulcer; diabetic amyotrophy with functional decline"
    },
    {
      "disposition": "ICU admission",
      "criteria": "Sepsis from foot infection; autonomic crisis"
    },
    {
      "disposition": "Neurology follow-up",
      "criteria": "q3-6 months during treatment optimization; annually when stable"
    },
    {
      "disposition": "Podiatry follow-up",
      "criteria": "q3 months if high-risk feet; annually if low-risk"
    },
    {
      "disposition": "Urgent follow-up",
      "criteria": "New weakness, new ulcer, worsening pain despite treatment"
    }
  ]
}